Department of Neurology, Harvard Medical School, Massachusetts General Hospital, Boston, MA, USA.
Department of Neurology, Cleveland Clinic, Neurological Institute, Cleveland, OH, USA.
Lung. 2021 Dec;199(6):603-610. doi: 10.1007/s00408-021-00491-1. Epub 2021 Nov 15.
Acute respiratory distress syndrome (ARDS) in patients with traumatic brain injury (TBI) is associated with increased mortality. Information on the prevalence of ARDS and its neurological outcome after TBI is sparse. We aimed to systematically review the prevalence, risk factors, and outcome of ARDS in TBI population.
PubMed and four other databases (Embase, Cochrane Library, Web of Science Core Collection, and Scopus) from inception to July 6, 2020.
Randomized controlled trials (RCTs) and observational studies in patients older than 18 years old.
Two independent reviewers extracted the data. Study quality was assessed by the Cochrane Risk of Bias tool for RCTs, the Newcastle-Ottawa Scale for cohort and case-control studies. Good neurological outcome was defined as Glasgow Outcome Scale ≥ 4. Random-effects meta-analyses were conducted to estimate pooled outcome prevalence and their 95% confidence intervals (CI).
We included 20 studies (n = 2830) with median age of 44 years (interquartile range [IQR] = 35-47, 64% male) and 79% (n = 2237) suffered severe TBI. In meta-analysis, 19% patients (95% CI = 0.13-0.27, I = 93%) had ARDS after TBI. The median time from TBI to ARDS was 3 days (IQR = 2-5). Overall survival at discharge for the TBI cohort was 70% (95% CI = 0.64-0.75; I = 85%) and good neurological outcome at any time was achieved in 31% of TBI patients (95% CI = 0.23-0.40; I = 88%). TBI cohort without ARDS had higher survival (67% vs. 57%, p = 0.01) and good neurological outcomes (34% vs. 23%, p = 0.02) compared to those with ARDS. We did not find any specific risk factors for developing ARDS.
In this meta-analysis, approximately one in five patients had ARDS shortly after TBI with the median time of 3 days. The presence of ARDS was associated with worse neurological outcome and mortality in TBI. Further research on prevention and intervention strategy of TBI-associated ARDS is warranted.
创伤性脑损伤(TBI)患者并发急性呼吸窘迫综合征(ARDS)与死亡率增加有关。关于 TBI 患者 ARDS 的患病率及其神经预后的信息很少。我们旨在系统地综述 TBI 人群中 ARDS 的患病率、危险因素和结局。
从建库至 2020 年 7 月 6 日,PubMed 及另外 4 个数据库(Embase、Cochrane 图书馆、Web of Science 核心合集和 Scopus)。
纳入大于 18 岁患者的随机对照试验(RCT)和观察性研究。
两名独立的审查员提取数据。使用 Cochrane 偏倚风险工具评估 RCT 研究质量,使用纽卡斯尔-渥太华量表评估队列和病例对照研究质量。良好的神经结局定义为格拉斯哥结局量表评分≥4 分。采用随机效应荟萃分析来估计汇总结局的患病率及其 95%置信区间(CI)。
我们纳入了 20 项研究(n=2830),患者的中位年龄为 44 岁(四分位间距[IQR]=35-47,64%为男性),79%(n=2237)患有严重 TBI。荟萃分析显示,19%(95%CI=0.13-0.27,I=93%)的 TBI 患者并发 ARDS。从 TBI 到 ARDS 的中位时间为 3 天(IQR=2-5)。TBI 队列的出院时总体生存率为 70%(95%CI=0.64-0.75;I=85%),TBI 患者中任何时间的良好神经结局达到 31%(95%CI=0.23-0.40;I=88%)。与 ARDS 患者相比,无 ARDS 的 TBI 患者的生存率(67%比 57%,p=0.01)和良好的神经结局(34%比 23%,p=0.02)更高。我们未发现发生 ARDS 的任何特定危险因素。
在本荟萃分析中,大约五分之一的 TBI 患者在伤后短期内出现 ARDS,中位时间为 3 天。ARDS 的存在与 TBI 患者的不良神经结局和死亡率相关。需要进一步研究 TBI 相关 ARDS 的预防和干预策略。